RecruitingNCT05509010

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry (APOLLO)

Sponsor

National Heart Centre Singapore

Enrollment

8,000 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Coronary Stenosis CAD Plaques; Epicardial

Summary

The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.

Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called CTCA for people with cad, coronary artery disease, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 21 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.